Medical/Pharmaceuticals
Ascentage Pharma and Innovent Biologics Reach Multifaceted Strategic Agreement Totaling US$245 Million Including Commercialization of Olverembatinib (HQP1351) in China, Joint Clinical Development of Lisaftoclax (APG-2575) and Equity Investment
SUZHOU, China, and ROCKVILLE, Md., July 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics (1801.HK, "Innovent"), today an...
2021-07-15 01:43
5249
Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment
SAN FRANCISCO and SUZHOU, China, July 14, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-14 23:48
15452
Frost & Sullivan Best Practices Recognition Honors Industry-leading Companies at the 2021 Asia-Pacific Virtual Awards Ceremony
Sixteen companies recognized for their exemplary performance and valuable contributions in shaping new trends acrossAsia-Pacific SINGAPORE, July 14, 2021 /PRNewswire/ -- Frost & Sullivan honored leading companies in the region at the 19th annual Asia-Pacific Best Practices Awards on 14 July. At ...
2021-07-14 18:28
1588
Antengene Submits New Drug Application for Selinexor in Taiwan for the Treatment of Three Indications in Hematologic Malignancies
SHANGHAI and HONG KONG, July 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...
2021-07-14 10:00
21211
UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood®- Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer'
LONDON, July 14, 2021 /PRNewswire/ -- Datar Cancer Genetics, a world leading non-invasive cancer analytics and diagnostics company having its Research Head Quarters at Nasik,India, announced the publication of the internationally recognized MedTech Innovation Briefing (MIB) from theUnited Kingdom...
2021-07-14 07:00
7213
ZEISS Introduces the Fully Integrated, Data-Driven Medical Ecosystem
JENA, Germany and DUBLIN, Calif., July 13, 2021 /PRNewswire/ -- ZEISS today announced its newZEISS Medical Ecosystem, a fully integrated environment where a combination of devices, data management, applications and services drive continuous improvement of patient outcomes. This ecosystem distinct...
2021-07-13 22:00
1982
Envision Donates Covid-19 Medical Equipment to India
SHANGHAI, July 13, 2021 /PRNewswire/ -- Envision Group, a world-leading green technology company, recently donated dozens of oxygen concentrators and 44,000 protective masks toIndia in wake of the shortage of essential medical supplies during the second wave of the Covid-19 pandemic. Mahara...
2021-07-13 21:19
1891
Global consulting firm Star acquires Pro4People, creating powerhouse in MedTech development and regulatory consulting
WROCLAW, Poland, July 13, 2021 /PRNewswire/ -- Star, a global technology company connecting end-to-end strategy, design and engineering services, announced its acquisition of Pro4People, a leading software consultancy based in Wroclaw,Poland, specializing in regulated MedTech and Digital Healthca...
2021-07-13 20:59
1668
Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus
* Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. * The new CE-IVD marked variants detection kit to differentiate 10 major COVID-19 variants including the...
2021-07-13 20:00
1387
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China
SHANGHAI, July 13, 2021 /PRNewswire/ -- Everest Medicines
2021-07-13 19:47
5550
Ascletis Announces Dosing of the First Cohort of Healthy Subjects in the FXR Agonist ASC42 Bridging Study for Chronic Hepatitis B Indication in China
--This bridging study to select doses for the Phase II trial in China in patients with chronic hepatitis B (CHB) --ASC42 clinical trials are being conducted in the U.S. and China for non-alcoholic steatohepatitis (NASH) and CHB. HANGZHOU and SHAOXING, China, July 13, 2021 /PRNewswire/ -- A...
2021-07-13 08:30
2423
Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
PARIS, July 12, 2021 /PRNewswire/ -- Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced todaythat they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological ...
2021-07-12 23:00
1385
Werfen Companies Unite Under One Name And One Brand
BARCELONA, Spain, July 12, 2021 /PRNewswire/ -- Werfen today announced that its companies, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, are uniting under one name and one brand—Werfen. As part of this effort, the Company has completed organizational transition...
2021-07-12 20:00
1533
ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio
WOODINVILLE, Wash. and SUZHOU, China, July 12, 2021 /PRNewswire/ -- ProfoundBio announced the closing of a $55+ million Series A financing round led byLilly Asia Venture and co-led by LYFE Capital, with participation from Sequoia Capital China and Oriza. All investors from the Series Pre-A finan...
2021-07-12 17:00
2067
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies
HOUSTON and SINGAPORE, July 12, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce major improvements in treatment outcomes, andThe University of Texas MD Anderson Cancer Ce...
2021-07-12 17:00
1297
Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem(TM) into clinic
Novel source of stem cells in full-term amniotic fluid provides basis for broad pipeline LUND, Sweden, July 12, 2021 /PRNewswire/ -- Amniotics AB (publ) ("Amniotics" or the "Company"), a stem cell therapy company has raisedSEK60 million through its recent listing on Nasdaq First North Growth Mar...
2021-07-12 14:00
1700
New Study Demonstrates Significantly Increased Healing Rates with NATROX® Oxygen Wound Therapy
Treatment offers hope for patients with long-standing chronic wounds CAMBRIDGE, England, July 12, 2021 /PRNewswire/ -- Inotec AMD, manufacturer of NATROX® Oxygen Wound Therapy, is delighted to share newly published randomised controlled trial (RCT) results[1]. The trial involved 145 patients with...
2021-07-12 13:00
1202
Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent
SHANGHAI, July 12, 2021 /PRNewswire/ -- Everest Medicines
2021-07-12 12:42
3842
LEAD Horizon: How Vienna gargles out of lockdown
VIENNA, July 12, 2021 /PRNewswire/ -- With the initiative "everything gargles" Vienna got through the pandemic better in comparison to other European cities. Every day, up to 70.000 people participate in the simple gargle PCR testing to inquire their Covid-19 status. Following the example ofVienn...
2021-07-12 08:30
1812
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI323 (Anti-LAG-3/PD-L1 Bispecific Antibody) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, July 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-12 08:12
3594
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
9065
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
8421
Where does China's production capacity come from?
2024-05-10 12:01
8252
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4997